03/15/2021
Bay Biosciences provides high quality, clinical grade bio-specimens, cryogenically preserved sera (serum), plasma and peripheral blood mononuclear cells (PBMC) biofluid samples from patients diagnosed with antibody-mediated rejection (AMR).
The sera (serum), plasma and PBMC biofluid specimens are processed from patient’s peripheral whole-blood using customized collection and processing protocols. The antibody-mediated rejection (AMR) bio-specimens are collected from unique patients diagnosed with antibody-mediated rejection (AMR) and are provided to a valued pharmaceutical customer for research, diagnostics, discovery and drug development.
Detailed clinical data, cold agglutinin disease patients history, symptoms, complete blood count (CBC), elevated biomarker levels, genetic and metabolic information, histopathological findings, annotations associated with antibody-mediated rejection (AMR) patient’s specimens is provided to a valued customer for research, development and drug discovery. The antibody-mediated rejection (AMR) sera (serum), plasma and peripheral blood mononuclear cells (PBMC) biofluid are processed from patients peripheral whole-blood using customized collection and processing protocols.